Protara Therapeutics is trading 11.2% up at $3.07 in after-hours trading after closing at $2.76 on October 1, 2026; no clear catalyst has been identified.
- The move reverses part of a seven-session decline.
- The investor-relations page lists a September 8 conference-presentation announcement as its latest release; no October 1 release is shown.
- Major indices were mixed, and available evidence does not establish a broader-market explanation for the after-hours rise.